Fulgent Genetics: Oversold, Underpriced, and Misunderstood
Fulgent Genetics (FLGT) trades near cycle lows at ~$14.19 despite a technology-led testing platform, a clean balance sheet, and valuation multiples that look cheap relative to recovery scenarios. The market has punished the stock for legal inquiries and margin volatility; that reaction appears overdone. This trade idea lays out a mid-term long with…